Insulin ointment shows promise for speeding up wound healing in rare blistering disease
NCT ID NCT07461103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether applying insulin directly to skin sores helps them heal faster in people with pemphigus vulgaris, a rare autoimmune blistering disease. Twenty patients each had three similar sores treated with either long-acting insulin, short-acting insulin, or a saltwater control for 14 days. The goal was to see which treatment led to the quickest healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE BLISTERING DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexandria main university hospital, Department of Dermatology and Venereology
Alexandria, 22301, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at blistering skin disease
- Can an extra shot boost COVID protection in autoimmune patients?
- Laser and steroid mouthwash aim to tame painful mouth sores in autoimmune disease
- Scientists probe hidden clot risks in autoimmune skin disorders
- Study reveals vaccine response in Immune-Compromised patients
- Researchers track blistering skin disease to pave way for better treatments